{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:04:25Z","timestamp":1791993865421,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Korea National Institute of Health Research project","award":["2025-ER1206-00"],"award-info":[{"award-number":["2025-ER1206-00"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Remission has emerged as a therapeutic goal in asthma, but most studies in severe asthma have focused on biologic-treated patients in controlled settings. Real-world data from Asian populations are scarce. We aimed to evaluate the achievement and predictors of asthma remission in Korean patients with severe asthma using a nationwide prospective cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed 405 patients with severe asthma from the Korean Severe Asthma Registry (KoSAR) who completed 12-month follow-up. Remission was classified at 12 and 24 months as complete clinical remission (CCR; ACT\u2009\u2265\u200920, no exacerbations, no oral corticosteroid [OCS] use, and FEV\u2081 \u226580% or improvement\u2009\u2265\u2009100 mL), clinical remission (CR; first three criteria), partial remission (PR; \u22651 criterion), and no remission (NR; none). Ordinal logistic regression identified baseline predictors of higher remission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At 12 months, CCR, CR, PR, and NR were achieved in 5.9%, 18.3%, 67.9%, and 7.9% of participants. Among those with 24-month follow-up (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009139), remission status was largely stable. Higher baseline ACT score (OR: 1.19, 95% CI 1.12\u20131.27) predicted remission, while maintenance OCS use (OR: 0.11, 95% CI 0.05\u20130.25) and chronic cough (OR: 0.39, 95% CI 0.17\u20130.89) were negatively associated. Remission groups had better baseline lung function, fewer exacerbations, and low WBC counts. Baseline biologic use was more common in CCR, CR groups, whereas NR patients more frequently received methylxanthines, macrolides, and OCS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Clinical predictors, including asthma control, OCS use, and chronic cough may help guide remission-focused strategies in the treatment of severe asthma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-025-03451-y","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T03:32:56Z","timestamp":1766806376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Asthma remission and its predictors in severe asthma: real-world study from the Korean severe asthma registry"],"prefix":"10.1186","volume":"27","author":[{"given":"Seung-Eun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Keun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noeul","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngsoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-Seok","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Woon","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-In","family":"Rhyou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Woo","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Woo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taehoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga-Young","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Hee","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Soo","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Yoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Suk","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Ri","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jung","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hee","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Hye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwa Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Ki","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Jung","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heung-Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Jung","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Heon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5224-3077","authenticated-orcid":false,"given":"So-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"key":"3451_CR1","unstructured":"GINA. Global Strategy for Asthma Management and Prevention. 2025 [cited 2025; Available from: https:\/\/ginasthma.org\/gina-reports\/"},{"issue":"5","key":"3451_CR2","doi-asserted-by":"publisher","first-page":"2102583","DOI":"10.1183\/13993003.02583-2021","volume":"60","author":"D Thomas","year":"2022","unstructured":"Thomas D, McDonald VM, Pavord ID, Gibson PG. Asthma remission: what is it and how can it be achieved? Eur Respir J. 2022;60(5):2102583. https:\/\/doi.org\/10.1183\/13993003.02583-2021.","journal-title":"Eur Respir J"},{"issue":"3","key":"3451_CR3","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jaci.2019.12.006","volume":"145","author":"A Menzies-Gow","year":"2020","unstructured":"Menzies-Gow A, Bafadhel M, Busse WW, Casale TB, Kocks JWH, Pavord ID, et al. An expert consensus framework for asthma remission as a treatment goal. J Allergy Clin Immunol. 2020;145(3):757\u201365. https:\/\/doi.org\/10.1016\/j.jaci.2019.12.006.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"3451_CR4","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.jaip.2024.01.044","volume":"12","author":"WW Busse","year":"2024","unstructured":"Busse WW, Chupp G, Thomas C, Stach-Klysh A, Oppenheimer J. Targeting asthma remission as the next therapeutic step toward improving disease control. J Allergy Clin Immunol Pract. 2024;12(4):894\u2013903. https:\/\/doi.org\/10.1016\/j.jaip.2024.01.044.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"3451_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/rheumatology\/kez278","volume":"59","author":"L Schlager","year":"2020","unstructured":"Schlager L, Loiskandl M, Aletaha D, Radner H. Predictors of successful discontinuation of biologic and targeted synthetic DMARDs in patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review. Rheumatology (Oxford). 2020;59(2):324\u201334. https:\/\/doi.org\/10.1093\/rheumatology\/kez278.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"3451_CR6","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/ecco-jcc\/jjab173","volume":"16","author":"JF Ilvemark","year":"2022","unstructured":"Ilvemark JF, Hansen T, Goodsall TM, Seidelin JB, Al-Farhan H, Allocca M, et al. Defining transabdominal intestinal ultrasound treatment response and remission in inflammatory bowel disease: systematic review and expert consensus statement. J Crohns Colitis. 2022;16(4):554\u201380. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab173.","journal-title":"J Crohns Colitis"},{"issue":"12","key":"3451_CR7","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1016\/j.jaip.2023.07.041","volume":"11","author":"GW Canonica","year":"2023","unstructured":"Canonica GW, Blasi F, Carpagnano GE, Guida G, Heffler E, Paggiaro P, et al. Severe asthma network Italy definition of clinical remission in severe asthma: a Delphi consensus. The Journal of Allergy and Clinical Immunology: In Practice. 2023;11(12):3629\u201337. https:\/\/doi.org\/10.1016\/j.jaip.2023.07.041.","journal-title":"The Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"1","key":"3451_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S2213-2600(24)00304-7","volume":"13","author":"M Lommatzsch","year":"2025","unstructured":"Lommatzsch M, Virchow JC. Asthma remission: a call for a globally standardised definition. Lancet Respir Med. 2025;13(1):2\u20133. https:\/\/doi.org\/10.1016\/S2213-2600(24)00304-7.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"3451_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacig.2025.100431","volume":"4","author":"M Ishizuka","year":"2025","unstructured":"Ishizuka M, Sugimoto N, Kobayashi K, Takeshita Y, Imoto S, Koizumi Y, et al. Clinical remission of mild-to-moderate asthma: rates, contributing factors, and stability. Journal of Allergy and Clinical Immunology: Global. 2025;4(2):100431. https:\/\/doi.org\/10.1016\/j.jacig.2025.100431.","journal-title":"Journal of Allergy and Clinical Immunology: Global"},{"issue":"2","key":"3451_CR10","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/all.15867","volume":"79","author":"D Thomas","year":"2024","unstructured":"Thomas D, McDonald VM, Stevens S, Harvey ES, Baraket M, Bardin P, et al. Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients. Allergy. 2024;79(2):384\u201392. https:\/\/doi.org\/10.1111\/all.15867.","journal-title":"Allergy"},{"issue":"3","key":"3451_CR11","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jaip.2020.10.035","volume":"9","author":"A Menzies-Gow","year":"2021","unstructured":"Menzies-Gow A, Szefler SJ, Busse WW. The relationship of asthma biologics to remission for asthma. J Allergy Clin Immunol Pract. 2021;9(3):1090\u20138. https:\/\/doi.org\/10.1016\/j.jaip.2020.10.035.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"3451_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jaip.2024.10.009","volume":"13","author":"ID Pavord","year":"2025","unstructured":"Pavord ID, Rabe KF, Israel E, Szefler SJ, Brusselle G, Pandit-Abid N, et al. Dupilumab induces long-term on-treatment clinical remission in patients with type 2 asthma. The Journal of Allergy and Clinical Immunology: In Practice. 2025;13(1):132\u201342. https:\/\/doi.org\/10.1016\/j.jaip.2024.10.009.","journal-title":"The Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"1","key":"3451_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12931-024-02812-3","volume":"25","author":"I Farinha","year":"2024","unstructured":"Farinha I, Heaney LG. Barriers to clinical remission in severe asthma. Respir Res. 2024;25(1):178. https:\/\/doi.org\/10.1186\/s12931-024-02812-3.","journal-title":"Respir Res"},{"issue":"3","key":"3451_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/MCP.0000000000001068","volume":"30","author":"M Lommatzsch","year":"2024","unstructured":"Lommatzsch M. Remission in asthma. Curr Opin Pulm Med. 2024;30(3):325\u20139. https:\/\/doi.org\/10.1097\/MCP.0000000000001068.","journal-title":"Curr Opin Pulm Med"},{"issue":"2","key":"3451_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3904\/kjim.2021.403","volume":"37","author":"SH Kim","year":"2022","unstructured":"Kim SH, Lee H, Park SY, Park SY, Song WJ, Kim JH, et al. The Korean severe asthma registry (KoSAR): real world research in severe asthma. Korean J Intern Med. 2022;37(2):249\u201360. https:\/\/doi.org\/10.3904\/kjim.2021.403.","journal-title":"Korean J Intern Med"},{"issue":"6","key":"3451_CR16","doi-asserted-by":"publisher","first-page":"2300819","DOI":"10.1183\/13993003.00819-2023","volume":"62","author":"PJ McDowell","year":"2023","unstructured":"McDowell PJ, McDowell R, Busby J, Eastwood MC, Patel PH, Jackson DJ, et al. Clinical remission in severe asthma with biologic therapy: an analysis from the UK severe asthma registry. Eur Respir J. 2023;62(6):2300819. https:\/\/doi.org\/10.1183\/13993003.00819-2023.","journal-title":"Eur Respir J"},{"key":"3451_CR17","doi-asserted-by":"publisher","first-page":"1150162","DOI":"10.3389\/fimmu.2023.1150162","volume":"14","author":"I Pavord","year":"2023","unstructured":"Pavord I, Gardiner F, Heaney LG, Domingo C, Price RG, Pullan A, et al. Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: analysis of the REDES study. Front Immunol. 2023;14:1150162. https:\/\/doi.org\/10.3389\/fimmu.2023.1150162.","journal-title":"Front Immunol"},{"key":"3451_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.rmed.2016.06.017","volume":"117","author":"LE Tuomisto","year":"2016","unstructured":"Tuomisto LE, Ilmarinen P, Niemel\u00e4 O, Haanp\u00e4\u00e4 J, Kankaanranta T, Kankaanranta H. A 12-year prognosis of adult-onset asthma: Sein\u00e4joki adult asthma study. Respir Med. 2016;117:223\u20139. https:\/\/doi.org\/10.1016\/j.rmed.2016.06.017.","journal-title":"Respir Med"},{"issue":"4","key":"3451_CR19","doi-asserted-by":"publisher","first-page":"00620","DOI":"10.1183\/23120541.00620-2020","volume":"6","author":"L Almqvist","year":"2020","unstructured":"Almqvist L, R\u00f6nmark E, Stridsman C, Backman H, Lindberg A, Lundb\u00e4ck B, et al. Remission of adult-onset asthma is rare: a 15-year follow-up study. ERJ Open Research. 2020;6(4):00620\u20132020. https:\/\/doi.org\/10.1183\/23120541.00620-2020.","journal-title":"ERJ Open Research"},{"issue":"7","key":"3451_CR20","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S2213-2600(23)00187-X","volume":"11","author":"K Lai","year":"2023","unstructured":"Lai K, Satia I, Song WJ, Wang G, Niimi A, Pattemore P, et al. Cough and cough hypersensitivity as treatable traits of asthma. Lancet Respir Med. 2023;11(7):650\u201362. https:\/\/doi.org\/10.1016\/S2213-2600(23)00187-X.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"3451_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jaip.2025.01.006","volume":"13","author":"HY Lee","year":"2025","unstructured":"Lee HY, Lee Y, Lee SE, Sim DW, Kang N, Lee BJ, et al. Relationships between chronic cough and asthma control and quality of life in patients with severe asthma: a 6-month longitudinal analysis. The Journal of Allergy and Clinical Immunology: In Practice. 2025;13(3):533-541.e3. https:\/\/doi.org\/10.1016\/j.jaip.2025.01.006.","journal-title":"The Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"2","key":"3451_CR22","doi-asserted-by":"publisher","first-page":"00528","DOI":"10.1183\/23120541.00528-2020","volume":"7","author":"WJ Song","year":"2021","unstructured":"Song WJ, Won HK, Lee SY, Park HK, Cho YS, Chung KF, et al. Patients\u2019 experiences of asthma exacerbation and management: a qualitative study of severe asthma. ERJ Open Res. 2021;7(2):00528\u20132020. https:\/\/doi.org\/10.1183\/23120541.00528-2020.","journal-title":"ERJ Open Res"},{"issue":"1","key":"3451_CR23","doi-asserted-by":"publisher","first-page":"00442","DOI":"10.1183\/23120541.00442-2022","volume":"9","author":"J Holmes","year":"2023","unstructured":"Holmes J, O\u2019Neill V, McGarvey LP, Heaney LG. Adverse perception of cough in patients with severe asthma: a discrete choice experiment. ERJ Open Res. 2023;9(1):00442\u20132022. https:\/\/doi.org\/10.1183\/23120541.00442-2022.","journal-title":"ERJ Open Res"},{"issue":"3","key":"3451_CR24","doi-asserted-by":"publisher","first-page":"00864","DOI":"10.1183\/23120541.00864-2023","volume":"10","author":"EC Majellano","year":"2024","unstructured":"Majellano EC, Yorke J, Clark VL, Gibson PG, Smith AJ, Holmes LJ, et al. The illness burden of severe asthma contrasted to people with mild-to-moderate asthma: a qualitative study. ERJ Open Research. 2024;10(3):00864\u20132023. https:\/\/doi.org\/10.1183\/23120541.00864-2023.","journal-title":"ERJ Open Research"},{"issue":"4","key":"3451_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00408-024-00710-5","volume":"202","author":"HY Lee","year":"2024","unstructured":"Lee HY, Lee Y, Lee JH, Lee SE, Sim DW, Kang N, et al. Association of cough severity with asthma control and quality of life in patients with severe asthma. Lung. 2024;202(4):405\u201314. https:\/\/doi.org\/10.1007\/s00408-024-00710-5.","journal-title":"Lung"},{"issue":"3","key":"3451_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2500\/aap.2022.43.220022","volume":"43","author":"SJ Deng","year":"2022","unstructured":"Deng SJ, Wang J, Liu L, Zhang X, Gibson PG, Chen ZH, et al. Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes. Allergy Asthma Proc. 2022;43(3):209\u201319. https:\/\/doi.org\/10.2500\/aap.2022.43.220022.","journal-title":"Allergy Asthma Proc"},{"issue":"6","key":"3451_CR27","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.jaip.2019.04.048","volume":"7","author":"S Diver","year":"2019","unstructured":"Diver S, Russell RJ, Brightling CE. Cough and eosinophilia. J Allergy Clin Immunol Pract. 2019;7(6):1740\u20137. https:\/\/doi.org\/10.1016\/j.jaip.2019.04.048.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"3451_CR28","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1164\/rccm.201911-2263OC","volume":"201","author":"Y Kanemitsu","year":"2020","unstructured":"Kanemitsu Y, Fukumitsu K, Kurokawa R, Takeda N, Suzuki M, Yap J, et al. Increased capsaicin sensitivity in patients with severe asthma is associated with worse clinical outcome. Am J Respir Crit Care Med. 2020;201(9):1068\u201377. https:\/\/doi.org\/10.1164\/rccm.201911-2263OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"3451_CR29","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.iac.2024.08.004","volume":"44","author":"O Rivera","year":"2024","unstructured":"Rivera O, Katial R, Hoyte FCL. Biologics in asthma: potential to achieve clinical remission. Immunol Allergy Clin North Am. 2024;44(4):725\u201336. https:\/\/doi.org\/10.1016\/j.iac.2024.08.004.","journal-title":"Immunol Allergy Clin North Am"},{"issue":"7","key":"3451_CR30","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1164\/rccm.202311-2192OC","volume":"210","author":"L Perez-de-Llano","year":"2024","unstructured":"Perez-de-Llano L, Scelo G, Tran TN, Le TT, Fager\u00e5s M, Cosio BG, et al. Exploring definitions and predictors of severe asthma clinical remission after biologic treatment in adults. Am J Respir Crit Care Med. 2024;210(7):869\u201380. https:\/\/doi.org\/10.1164\/rccm.202311-2192OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"3451_CR31","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/thoraxjnl-2012-202698","volume":"68","author":"GG Brusselle","year":"2013","unstructured":"Brusselle GG, VanderStichele C, Jordens P, Deman R, Slabbynck H, Ringoet V, et al. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial. Thorax. 2013;68(4):322\u20139. https:\/\/doi.org\/10.1136\/thoraxjnl-2012-202698.","journal-title":"Thorax"},{"issue":"5","key":"3451_CR32","doi-asserted-by":"publisher","first-page":"1901381","DOI":"10.1183\/13993003.01381-2019","volume":"54","author":"SA Hiles","year":"2019","unstructured":"Hiles SA, McDonald VM, Guilhermino M, Brusselle GG, Gibson PG. Does maintenance azithromycin reduce asthma exacerbations? An individual participant data meta-analysis. Eur Respir J. 2019;54(5):1901381. https:\/\/doi.org\/10.1183\/13993003.01381-2019.","journal-title":"Eur Respir J"},{"issue":"10095","key":"3451_CR33","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","volume":"390","author":"PG Gibson","year":"2017","unstructured":"Gibson PG, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, et al. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet. 2017;390(10095):659\u201368. https:\/\/doi.org\/10.1016\/S0140-6736(17)31281-3.","journal-title":"Lancet"},{"issue":"4","key":"3451_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.4168\/aair.2022.14.4.412","volume":"14","author":"JH Lee","year":"2022","unstructured":"Lee JH, Kim HJ, Park CS, Park SY, Lee H, Kim SH, et al. Clinical characteristics and disease burden of severe asthma according to oral corticosteroid dependence: real-world assessment from the Korean severe asthma registry (KoSAR). Allergy Asthma Immunol Res. 2022;14(4):412\u201323. https:\/\/doi.org\/10.4168\/aair.2022.14.4.412.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"4","key":"3451_CR35","doi-asserted-by":"publisher","first-page":"1800703","DOI":"10.1183\/13993003.00703-2018","volume":"52","author":"T Volmer","year":"2018","unstructured":"Volmer T, Effenberger T, Trautner C, Buhl R. Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature. Eur Respir J. 2018;52(4):1800703. https:\/\/doi.org\/10.1183\/13993003.00703-2018.","journal-title":"Eur Respir J"},{"issue":"6","key":"3451_CR36","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.anai.2023.08.609","volume":"131","author":"M Blaiss","year":"2023","unstructured":"Blaiss M, Oppenheimer J, Corbett M, Bacharier L, Bernstein J, Carr T, et al. Consensus of an American College of Allergy, Asthma, and Immunology, American Academy of Allergy, Asthma, and Immunology, and American Thoracic Society workgroup on definition of clinical remission in asthma on treatment. Ann Allergy Asthma Immunol. 2023;131(6):782\u20135. https:\/\/doi.org\/10.1016\/j.anai.2023.08.609.","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03451-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03451-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03451-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:02:04Z","timestamp":1767913324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-025-03451-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3451"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03451-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7716039\/v1","asserted-by":"object"}]},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Hanyang University Hospital (IRB No. HYUH-202010015), and by the institutional review boards of all participating centers. Written informed consent was obtained from all patients. The study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}